Article
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
JAMA oncology - 1 Sept 2018
Carlo Maria I, Mukherjee Semanti, Mandelker Diana, Vijai Joseph, Kemel Yelena, Zhang Liying, Knezevic Andrea, Patil Sujata, Ceyhan-Birsoy Ozge, Huang Kuo-Cheng, Redzematovic Almedina, Coskey Devyn T, Stewart Carolyn, Pradhan Nisha, Arnold Angela G, Hakimi A Ari, Chen Ying-Bei, Coleman Jonathan A, Hyman David M, Ladanyi Marc, Cadoo Karen A, Walsh Michael F, Stadler Zsofia K, Lee Chung-Han, Feldman Darren R, Voss Martin H, Robson Mark, Motzer Robert J, Offit Kenneth
Abstract excerpt
Importance: Identification of patients with hereditary renal cell carcinoma (RCC) is important for cancer screening and, in patients with advanced disease, for guiding treatment. The prevalence of cancer-related germline mutations in patients with advanced RCC and the phenotypes associated with some rare mutations are unknown. Objectives: To examine the prevalence of germline mutations in both known RCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
